Two‑stage diphenhydramine improves early recovery in women after video‑assisted thoracoscopic surgery: a randomized controlled trial

Authors:

Abstract
Purpose Thoracic paravertebral block (TPVB) provides effective analgesia for video-assisted thoracoscopic surgery (VATS). However, even when pain is well-controlled by TPVB, female patients remain at high risk for postoperative nausea and vomiting (PONV) and sleep disturbances because of non-analgesic factors, such as hormonal and central emetic pathways. We investigated whether adding a two-stage diphenhydramine regimen to TPVB-based multimodal analgesia improves early recovery quality. Methods In this prospective, randomized, double-blind, placebo-controlled trial, 80 women (ASA I–III) scheduled for elective VATS pulmonary resection were randomized to receive a two-stage diphenhydramine regimen (0.2 mg/kg bolus at chest closure followed by 0.5 mg/kg via postoperative patient-controlled intravenous analgesia [PCIA]) or placebo (normal saline). All patients received standardized TPVB with 20 mL 0.4% ropivacaine, PCIA with sufentanil/ondansetron, and intravenous dexamethasone 10 mg. The primary outcome was the 24-h Quality of Recovery-15 (QoR-15) score. Secondary outcomes included sleep quality, PONV incidence, pain scores, rescue medication requirements, and adverse events. Results The diphenhydramine group exhibited a significantly higher median 24 h QoR-15 score (127 [IQR 121–134.75] vs. placebo 119.5 [IQR 108.25–130.75], P = 0.033). This group also demonstrated markedly better sleep quality (lower Athens Insomnia Scale scores at 24 and 48 h, P < 0.05) and a significantly reduced incidence of vomiting (10% vs. 40%, P = 0.004). Overall PONV rates and other secondary outcomes were comparable, with no difference in adverse events. Conclusions Adding a two-stage diphenhydramine regimen to TPVB-based multimodal analgesia significantly improves early recovery quality, enhances postoperative sleep, and reduces vomiting in women after VATS, without increasing adverse events. Clinical trial registration Chinese Clinical Trial Registry (ChiCTR2500097837).
Funding Information
  • Kunming Health Science and Technology Talent Program (2024-SW(Reserving)-22)
  • Chuncheng Youth Top-notch Talent Support Program (C202014009)

This publication has 25 references indexed in Scilit: